Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception - 1 Jun 2000

Spannagl M, Heinemann L A, Schramm W

Abstract excerpt

BACKGROUND: Major concern was raised by an earlier study regarding oral contraceptive use in women with the factor V Leiden mutation. A more than 30-fold increase in relative risk for venous thromboembolism was reported; for homozygotes, the relative risk was as much as 100-fold or more. OBJECTIVE: To replicate the reported risk estimates with a new population-based case-control study. METHODS: Eighty women with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Contraceptives, Oral
Share to Contraindications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor V

Share to Germany

Share to Odds Ratio

Share to Thromboembolism

Share to Venous Thrombosis

Source

Identifiers

PMID: 10943572
DOI: 10.1080/13625180008500383

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?PMID 10943572Read ↗

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.Semantic proximity Read ↗

Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.Semantic proximity Read ↗

Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.Semantic proximity Read ↗

Factor V Leiden Mutation and the Risks for Thromboembolic Disease: A Clinical PerspectiveSemantic proximity Read ↗

Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.Semantic proximity Read ↗

Combined Effect of Factor V Leiden and Prothrombin 20210A on the Risk of Venous ThromboembolismSemantic proximity Read ↗

Factor V Leiden: should all women be screened prior to commencing the contraceptive pill?Semantic proximity Read ↗

Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden.Semantic proximity Read ↗

Impact of double heterozygosity for Factor V Leiden and Prothrombin G20210A on the thrombotic phenotype.Semantic proximity Read ↗

Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.Semantic proximity Read ↗

Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review.Semantic proximity Read ↗

Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.